Literature DB >> 7985817

Epidemiologic perspectives on Enterobacter for the infection control professional.

J W Chow1, V L Yu, D M Shlaes.   

Abstract

Enterobacter species have emerged as important nosocomial pathogens. Common reservoirs for these organisms include wounds and the gastrointestinal, urinary, and respiratory tracts. Enterobacter bacteremia typically occurs in patients with long-standing underlying illnesses who received antimicrobial agents before their bacteremia. The wide use of broad-spectrum antibiotics has contributed to the increased prominence of Enterobacter infections. Enterobacter species have a propensity to emerge resistant to the antibiotic therapy administered. Plasmid analysis, restriction endonuclease analysis of total cellular DNA, pulsed-field electrophoresis, and ribotyping can be valuable in investigating the spread of antibiotic-resistant strains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985817     DOI: 10.1016/0196-6553(94)90067-1

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  10 in total

1.  Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report.

Authors:  Ian Musil; Vanessa Jensen; Jolyon Schilling; Boyd Ashdown; Tyler Kent
Journal:  J Med Case Rep       Date:  2010-05-09

2.  Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Authors:  Jacob Schlesinger; Shiri Navon-Venezia; Inna Chmelnitsky; Orly Hammer-Münz; Azita Leavitt; Howard S Gold; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  The impact of health care restructuring on nosocomial infections and transmission of antimicrobial resistant organisms.

Authors:  J Conly; L Johnston
Journal:  Can J Infect Dis       Date:  2001-09

Review 4.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Most Enterobacter aerogenes strains in France belong to a prevalent clone.

Authors:  C Bosi; A Davin-Regli; C Bornet; M Mallea; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-2007.

Authors:  M N Al-Hasan; B D Lahr; J E Eckel-Passow; L M Baddour
Journal:  Clin Microbiol Infect       Date:  2011-04       Impact factor: 8.067

7.  Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species.

Authors:  Mitchell J Schwaber; Camilla S Graham; Bruce E Sands; Howard S Gold; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

8.  Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units.

Authors:  A Davin-Regli; D Monnet; P Saux; C Bosi; R Charrel; A Barthelemy; C Bollet
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

9.  Carbapenem Resistance among Enterobacter Species in a Tertiary Care Hospital in Central India.

Authors:  Atul Khajuria; Ashok Kumar Praharaj; Mahadevan Kumar; Naveen Grover
Journal:  Chemother Res Pract       Date:  2014-08-10

10.  Clinical characteristics and outcomes of spontaneous bacterial peritonitis caused by Enterobacter species versus Escherichia coli: a matched case-control study.

Authors:  Seongman Bae; Taeeun Kim; Min-Chul Kim; Yong Pil Chong; Sung-Han Kim; Heungsup Sung; Young-Suk Lim; Sang-Oh Lee; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sang-Ho Choi
Journal:  BMC Infect Dis       Date:  2016-06-07       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.